The finance function in the development of high-potential biotech companies

Documents and media

Download André Mueller's biography

pdf (13.24 KB)

Speaker(s)

André Mueller

Member of the Board of Directors of Actelion Phamarceuticals Ltd

Events

Drug discovery in biotechnology. Biotechnology : What's the right business model?

Drug discovery in biotechnology.…

Drug discovery in biotechnology. Biotechnology in society : tomorrow's major challenges

Opening

Founding a biotech company. The role of venture capital

The finance function in the development of high-potential biotech companies

Seminar

24 Apr 2007

11:00 - 12:00

Jean-Christophe Galloux

The importance of intellectual property in biotechnology

Biotechnology and University. Biotechnology drug discovery : from idea to product

Academic medicine and therapeutic research

Biotechnology in society. Biotechnology and drug costs

Biotechnology and Big Pharma

Emerging infectious diseases

Biotechnology in the United States : reasons for success

The finance function in the development of high-potential biotech companies

Documents and media

Speaker(s)

André Mueller

Events

Setting up a biotech company. From innovative concept to first steps

Setting up a biotech company. From first steps to IPO

Drug discovery in biotechnology. Research or innovation ?

Biotechnology drug discovery. From product to drug

Biotechnology drug discovery. Biotech drug development

Drug discovery in biotechnology. Biotechnology : What's the right business model?

Drug discovery in biotechnology.…

Drug discovery in biotechnology. Biotechnology in society : tomorrow's major challenges

Opening

Founding a biotech company. The role of venture capital

The finance function in the development of high-potential biotech companies

The importance of intellectual property in biotechnology

Biotechnology and University. Biotechnology drug discovery : from idea to product

Academic medicine and therapeutic research

Biotechnology in society. Biotechnology and drug costs

Biotechnology and Big Pharma

Emerging infectious diseases

Biotechnology in the United States : reasons for success

Biotechnology in Spain : the example of the Botín Foundation

See also